Voythos

Join us in congratulating the 13th Annual Texas Life Science Forum Most Promising Companies, People's Choice and the Michael E. DeBakey Memorial Life Science Award winners! We recognized March Biosciences, ImmunoGenesis, Inc., Taurus Vascular, Foxo Technology, Voythos, Loop Robots, Case45, OmniNano Pharmaceuticals, Mongoose Bio Inc. and Rua Diagnostics as Most Promising companies, presented by Greater Houston Partnership. Cytecom was voted as People's Choice. Autoimmunity Biosolutions took home the Michael E. DeBakey Life Science Award, presented by BioHouston. 🏆 Read more about them via InnovationMap: https://lnkd.in/ger9aHPw 💡Learn more about all the companies in our company directory: https://lnkd.in/gfvrzj3K

Abide by startup karma: Do business with each other. Do business for each other. 💫 That’s one of the rules of engagement for our Capital Readiness Program. With Cohort 5 wrapping up today, we’re grateful to the 10 startups who focused, decelerated, and committed to transitioning from being task-oriented founders to CEOs equipped to engage with sophisticated investors, raise capital, and scale their businesses. 🤝 Thank you to our dedicated Investors-in-Residence who carved out 5 days to work alongside the cohort, offer invaluable guidance, and open up their networks to the startups. 🎯 The program wouldn’t be nearly as comprehensive without the participation of our subject matter experts who provided an added depth of knowledge into all aspects that touch health tech startups.   ➡ And last but certainly not least, thank you to Cozen O'Connor for sponsoring Cohort 5 of the Capital Readiness Program. 🌍 Startups: Calla Lily Clinical Care, CygnusMed, Inc., Dama Health, DriQ Health, Four-Forty, Hibiscus Health, InnoTech Precision Medicine, Inc. Kuana, ThirdLaw Molecular LLC, Voythos 🤝 Investors-in-Residence: Dan Sands of Factor 7 Medical, Julien L. Pham, MD, MPH of 3CC | Third Culture Capital, Vanessa Villaverde of California Health Care Foundation, Kim Frazier of EC Angels via Entrepreneurs' Center, Anish Srivastava of Telosity Ventures 🎯 Subject Matter Experts: Baker Tilly US, Cozen O’Connor, Duane Morris LLP, Independence Blue Cross, KPMG, NIH SEED, Layer 8 Security, PitchBook, Virtua

Abide by startup karma: Do business with each other. Do business for each other. 💫 That’s one of the rules of engagement for our Capital Readiness Program. With Cohort 5 wrapping up today, we’re grateful to the 10 startups who focused, decelerated, and committed to transitioning from being task-oriented founders to CEOs equipped to engage with sophisticated investors, raise capital, and scale their businesses. 🤝 Thank you to our dedicated Investors-in-Residence who carved out 5 days to work alongside the cohort, offer invaluable guidance, and open up their networks to the startups. 🎯 The program wouldn’t be nearly as comprehensive without the participation of our subject matter experts who provided an added depth of knowledge into all aspects that touch health tech startups.   ➡ And last but certainly not least, thank you to Cozen O'Connor for sponsoring Cohort 5 of the Capital Readiness Program. 🌍 Startups: Calla Lily Clinical Care, CygnusMed, Inc., Dama Health, DriQ Health, Four-Forty, Hibiscus Health, InnoTech Precision Medicine, Inc. Kuana, ThirdLaw Molecular LLC, Voythos 🤝 Investors-in-Residence: Dan Sands of Factor 7 Medical, Julien L. Pham, MD, MPH of 3CC | Third Culture Capital, Vanessa Villaverde of California Health Care Foundation, Kim Frazier of EC Angels via Entrepreneurs' Center, Anish Srivastava of Telosity Ventures 🎯 Subject Matter Experts: Baker Tilly US, Cozen O’Connor, Duane Morris LLP, Independence Blue Cross, KPMG, NIH SEED, Layer 8 Security, PitchBook, Virtua